The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): Preliminary safety and efficacy results from KEYNOTE-028.
 
Patrick Alexander Ott
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - AMRO Pharma (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Maria Elena Elez Fernandez
No Relationships to Disclose
 
Sandrine Hiret
No Relationships to Disclose
 
Dong-Wan Kim
Consulting or Advisory Role - Novartis
 
Rebecca Anne Moss
Honoraria - Ipsen
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Bayer (Inst); ImClone Systems (Inst)
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Tammy Winser
Employment - Merck
 
Sammy Yuan
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Bilal Piperdi
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen